Happi Staff01.07.20
Jane Wurwand (Founder and Chief Visionary), Aurelian Lis (Chief Executive Officer), and Dr. Angela Murphy (VP of Technology and Innovation) welcomed Dermalogica’s network of staff and professional skin therapists to a celebratory ribbon cutting and innovation event to reveal the latest product launch (BioLumin-C Eye Serum) and new lab facilities.
Research and development are at the core of Dermalogica and its global headquarters. In-house chemists and specialists work across all sectors of product development, from developing and perfecting product formulas, to using quality control to ensure product stability and packaging compatibility, to managing clinical trials, regulatory affairs, and science education for Dermalogica’s training curriculum.
Dermalogica has always been a leader in innovation and is continuing to accelerate (the brand created 17 products in the last year alone). With this, there was a pointed need to expand lab space to accommodate growth.
It’s Dermalogica’s commitment to spectacular innovations and product formulations that help propel professional skin therapists forward in their trade.
The new BioLumin-C Eye Serum ($70, launched 1/2/2020) is a supercharged Vitamin C eye serum that outsmarts visible premature skin aging caused by daily eye movements and environmental stress. Building on the success of Dermalogica’s BioLumin-C Serum, this lightweight serum for eyes delivers a highly-bioavailable Vitamin C complex to dramatically brighten and visibly firm the eye area.
Research and development are at the core of Dermalogica and its global headquarters. In-house chemists and specialists work across all sectors of product development, from developing and perfecting product formulas, to using quality control to ensure product stability and packaging compatibility, to managing clinical trials, regulatory affairs, and science education for Dermalogica’s training curriculum.
Dermalogica has always been a leader in innovation and is continuing to accelerate (the brand created 17 products in the last year alone). With this, there was a pointed need to expand lab space to accommodate growth.
It’s Dermalogica’s commitment to spectacular innovations and product formulations that help propel professional skin therapists forward in their trade.
The new BioLumin-C Eye Serum ($70, launched 1/2/2020) is a supercharged Vitamin C eye serum that outsmarts visible premature skin aging caused by daily eye movements and environmental stress. Building on the success of Dermalogica’s BioLumin-C Serum, this lightweight serum for eyes delivers a highly-bioavailable Vitamin C complex to dramatically brighten and visibly firm the eye area.